Source Language English Spanish French Arabic Portuguese Russian Chinese Hindi Bengali Urdu Indonesian Swahili Hebrew German Japanese Turkish Persian Ukrainian Pashto Dari Somali 13:02 GMT ¶ NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials...NanoViricides